ALKERMES reported $254.65M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
Acorda Therapeutics ACOR:US $ 23.13M 8.75M
Amgen AMGN:US $ 5203M 1325M
Biogen BIIB:US $ 2646.6M 897.3M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Coherus Biosciences CHRS:US $ 275.48M 50.2M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Gilead Sciences GILD:US $ 7000M 2704M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Horizon Pharma HZNP:US $ 1892.56M 249.43M
Intra Cellular Therapies ITCI:US $ 77.24M 52.06M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Marinus Pharmaceuticals MRNS:US $ 92.33M 33.99M
Minerva Neurosciences NERV:US $ 49.75M 5.19M
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Otsuka Holdings 4578:JP Y 456759M 33397M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Revance Therapeutics RVNC:US $ 69.42M 128.94M
Teva Pharmaceutical Industries TEVA:US $ 2058M 117M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M